Intermittent mechanical compression for prevention of travellers' thrombosis by Coppens, M. et al.
Acknowledgements
Wewould like to thankMrs Yvonne Gallistl for her secretarial
assistance. The technical assistance of Mrs Bettina Leschnik is
also gratefully acknowledged.
Disclosure of Conflict of Interests
The authors state that they have no conﬂict of interest.
References
1 Mertens I, Van Gaal LF. Obesity, haemostasis and the ﬁbrinolytic
system. Obes Rev 2002; 3: 85–101.
2 Rosito GA, D’Agostino RB, Massaro J, Lipinska I, Mittleman MA,
Sutherland P, Wilson PWF, Levy D, Muller JE, Toﬂer GH. Associ-
ation between obesity and a prothrombotic state: the Framingham
Oﬀspring Study. Thromb Haemost 2004; 91: 683–9.
3 Guagnano MT, Romano M, Falco A, Nutini M, Marinopiccoli M,
Manigrasso MR, Basili S, Davi G. Leptin increase is associated with
markers of the hemostatic system in obese healthy women. J Thromb
Haemost 2003; 1: 2330–4.
4 Gallistl S, Sudi KM, Borkenstein M, Troebinger M, Weinhandl G,
Muntean W. Determinants of haemostatic risk factors for coronary
heart disease in obese children and adolescents. Int J Obes RelatMetab
Disord 2000; 24: 1459–64.
5 Freedman DS, Khan LK, Serdula MK, Dietz WH, Srinivasan SR,
Berenson GS. The relation of childhood BMI to adult adiposity: the
Bogalusa Heart Study. Pediatrics 2005; 115: 22–7.
6 Mangge H, Schauenstein K, Stroedter L, Griesl A, Maerz W,
BorkensteinM. Low grade inﬂammation in juvenile obesity and type 1
diabetes associated with early signs of atherosclerosis. Exp Clin
Endocrinol Diabetes 2004; 112: 378–82.
7 Lijnen HR. Pleiotropic functions of plasminogen activator inhibitor-1.
J Thromb Haemost 2005; 3: 35–45.
8 Berenson GS, Srinivasan SR, Bao W, Newman 3rd WP, Tracy RE,
Wattigney WA. Association between multiple cardiovascular risk
factors and atherosclerosis in children and young adults. The Bogalusa
Heart Study. N Engl J Med 1998; 338: 1650–6.
9 Mann KG, Brummel K, Butenas S. What is all that thrombin for?
J Thromb Haemost 2003; 1: 1504–14.
10 Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E,
Wagenvoord R, Lecompte T, Beguin S. Calibrated automated
thrombin generation measurement in clotting plasma. Pathophysiol
Haemost Thromb 2003; 33: 4–15.
11 Pilz S, Horejsi R, Mo¨ller R, Almer G, Scharnagl G, Stojakovic T,
Dimitrova R, Weihrauch G, Borkenstein M, Maerz W, Schauenstein
K, Mangge H. Early atherosclerosis in obese juveniles is associated
with low serum levels of adiponectin. J Clin EndocrinolMetab 2005; 90:
4792–6.
12 De Pergola G, Pannacciulli N. Coagulation and ﬁbrinolysis abnor-
malities in obesity. J Endocrinol Invest 2002; 25: 899–904.
13 Marutsuka K, Hatakeyama K, Yamashita A, Asada Y. Role of
thrombogenic factors in the development of atherosclerosis. J Athero-
scler Thromb 2005; 12: 1–8.
14 Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ.
Fibrinolytic activity, clotting factors, and long-term incidence of
ischaemic heart disease in the Northwick Park Heart Study. Lancet
1993; 342: 1076–9.
15 Sudi KM, Gallistl S, Weinhandl G, Muntean W, Borkenstein MH.
Relationship between plasminogen activator inhibitor-1 antigen,
leptin, and fat mass in obese children and adolescents. Metabolism
2000; 49: 890–5.
16 FergusonMA,Gutin B, Owens S, LitakerM, Tracy RP, Allison J. Fat
distribution and hemostatic measures in obese children. Am J Clin
Nutr 1998; 67: 1136–40.
17 Vambergue A, Rugeri L, Gaveriaux V, Devos P,Martin A, FermonC,
Fontaine P, Jude B. Factor VII, tissue factor pathway inhibitor,
and monocyte tissue factor in diabetes mellitus: inﬂuence of type of
diabetes, obesity index, and age. Thromb Res 2001; 101: 367–75.
18 Cvirn G, Gallistl S, Leschnik B, Muntean W. Low tissue fac-
tor pathway inhibitor (TFPI) together with low antithrombin allows
suﬃcient thrombin generation in neonates. J ThrombHaemost 2003; 1:
263–8.
Intermittent mechanical compression for prevention
of travellers thrombosis
M. COPPENS ,* F . F . VAN DOORMAAL ,* A . J . M . SCHRE I J ER ,* F . R . ROSENDAAL and H . R . B U¨ LLER*
*Department of Vascular Medicine, Academic Medical Center, Amsterdam; Department of Clinical Epidemiology, Leiden University Medical
Center, Leiden; and Thrombosis and Haemostasis Research Center, Leiden University Medical Center, Leiden, the Netherlands
To cite this article: Coppens M, van Doormaal FF, Schreijer AJM, Rosendaal FR, Bu¨ller HR. Intermittent mechanical compression for prevention of
travellers thrombosis. J Thromb Haemost 2006; 4: 1836–8.
Long-haul air travel is associated with coagulation activation
and an increased risk of deep vein thrombosis and pulmonary
embolism. The overall risk of developing thrombosis is
approximately one per 5000 ﬂights lasting more than 4 h
[1,2]. This risk is further increased in people with additional risk
factors such as inherited thrombophilia, recent surgery and oral
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contraceptive use [2,3]. Whether this risk warrants pharmaco-
logical prophylaxis in high-risk travellers is controversial,
partly due to the concomitant risk of bleeding associated with
anticoagulants. Intermittent pneumatic compression devices
have been shown to increase venous outﬂow and to safely
reduce the risk of postoperative venous thrombosis with no
effect on bleeding [4]. Besides the effects on venous outﬂow,
intermittent compression has also been shown to increase
ﬁbrinolytic activity, which may contribute to the anti-
thrombotic effect [5].
In the present crossover study, we evaluated the effects of
intermittent mechanical compression in six volunteers (four
men, mean age 59 years, range 55–64), of whom none had a
history of venous thromboembolism or heart failure. Intermit-
tent mechanical compression was exerted by a lightweight
novel device (AviaFitTM, FlowMedic Ltd, Caesarea, Israel),
placed on both calves, and which generates 1 pulse min)1 with
a pressure of 45 mmHg during 7 s. The volunteers were
exposed to 4 h of strict seated immobilization on two separate
occasions. Half of the group had the devices placed the ﬁrst
day, the others on the second day of investigation, 1 week later.
Effects of intermittent compression were assessed by
measurement of venous ﬂow velocity, both proximally and
distally of the device, changes of lower extremity volume and
by markers of coagulation and ﬁbrinolysis. All measurements
were performed, and blood samples taken, immediately prior
to, and at the end of, the seated immobilization. Both peak
ﬂow velocity and mean ﬂow velocity over a 7.2-s interval in
the popliteal vein were measured using duplex ultrasonogra-
phy. Direction of ﬂow during compression distally from the
device was measured in the posterior tibial vein. The increase
in lower extremity volume was calculated by measuring the
volume immediately before and after immobilization at
30 cm from the ground using a water bath. Prothrombin
fragments 1 + 2, tissue type plasminogen activator antigen,
D-dimer and von Willebrand factor antigen were determined
with standard laboratory assays. Global ﬁbrinolytic capacity,
as described by Giddings et al. [6] was measured as a marker
of overall activity.
The mean ﬂow velocity in the popliteal vein after 4 h of
seated immobilization with intermittent compression was
increased almost twofold, as compared to seated immobiliza-
tion without the device. After adjustment for ﬂow velocity at
baseline, the absolute increase was 1.0 cm s)1 [95% conﬁdence
interval (CI%95) )1.1 to 3.1; Table 1]. The contraction of the
device induced a ﬂow pulse in the popliteal vein with a peak
ﬂow velocity measured at the end of the 4-h observation period
of 33.6 cm s)1, which was much higher than the peak ﬂow
velocity induced by normal inspiration and expiration
(5.3 cm s)1; Table 1). For comparison, mean peak ﬂow
velocity during maximal inspiration without the device is
approximately 9 cm s)1. Flow direction in the posterior tibial
vein during compression was upwards in all subjects. Themean
increase in lower-extremity volume induced by seated immo-
bilization was 91 mL without intermittent compression, as
compared to 73 mL with intermittent compression respect-
ively. Adjusted for values at baseline, the absolute difference
was )20 mL (CI%95 )77 to 36). With regard to laboratory
markers of coagulation and ﬁbrinolysis, the mean global
ﬁbrinolytic capacity was higher with intermittent compression,
as compared to without intermittent compression, with wide
conﬁdence limits (adjusted absolute difference 2.5 lg mL)1,
CI%95 )2.7 to 7.8; Table 1). Other markers of ﬁbrinolysis and
coagulation did not show an effect of intermittent compression.
Our objective in this pilot experiment was to assess the
potential of the novel device on ﬂow, lower extremity volume,
and hemostasis. The ﬁndings suggest that this device increases
peak ﬂow velocity in the popliteal vein to an extent which
cannot be achieved by maximal inspiration. In fact, the device
induced a peak ﬂow that was approximately 3-fold higher.
Furthermore, the increase in mean ﬂow velocity in between
compressions suggested that these pulsesmay have a carry-over
effect that stimulates venous outﬂow of the lower extremity.
There was no indication that the device induced backward
Table 1 Eﬀects on intermittent mechanical compression on venous ﬂow, lower-extremity volume and coagulation/ﬁbrinolysis after 4 h of seated
immobilization without or with intermittent mechanical compression
Mean
Adjusted absolute diﬀerence (95%CI)*Without IMC With IMC
Venous ﬂow
Flow velocity popliteal vein (cm s)1) 1.4 2.6 1.0 ()1.1 to +3.1)
Peak ﬂow (cm s)1) 5.3 33.6 28.3 (11.7 to +44.8)
Lower-extremity volume/venous stasis
Volume increase (mL) 91 73 )20 ()77 to +36)
Coagulation/ﬁbrinolysis
Prothrombin fragments 1 + 2 (nmol L)1) 0.6 0.5 )0.1 ()0.4 to +0.2)
Global ﬁbrinolytic capacity (lg mL)1) 4.0 6.1 2.5 ()2.7 to +7.8)
Tissue plasminogen activator antigen (ng mL)1) 4.7 5.3 0.6 ()0.6 to +1.7)
D-dimer (lg mL)1) 0.3 0.2 )0.1 ()0.3 to +0.1)
von Willebrand factor antigen (%) 129 125 )7 ()15 to +1)
IMC, intermittent mechanical compression.
*Adjusted for values at baseline. Unadjusted absolute diﬀerence. IMC, intermittent mechanical compression.
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ﬂow. Lower extremity volume measurement after immobiliza-
tion suggested a beneﬁcial effect of the device. Finally, with the
possible exception of the global ﬁbrinolytic capacity, we could
not detect any effect on systemic hemostasis.
Our ﬁndings warrant further experimental and clinical
evaluation as to whether this device may be useful in the
setting of prevention of air travel-related thrombosis.
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Graduated compression stockings are used to prevent deep
vein thrombosis (DVT) in elderly patients [1], a setting in which
physicians are often reluctant to order anticoagulant-based
prophylaxis for fear of bleeding complications. Although their
mechanism of action is probably multifactorial, graduated
compression stockings exert graded circumferential pressure
from distal to proximal segments of the lower limbs, increasing
venous outﬂow and reducing stasis within the leg veins [2].
Their use is recommended only in patients at high risk for
bleeding complications or as an adjunct to anticoagulant-based
prophylaxis [3]. The aim of this study was to identify baseline
characteristics and treatments associated with the use of
graduated compression stockings in elderly patients with
restricted mobility.
We analyzed the individual data for 1664 patients, 65 years
of age or older, whowere enrolled in two cross-sectional studies
conducted at 50 hospital-based postacute care facilities in
France in 2001 and 2003. Postacute care departments receive
patients who typically have complicated conditions and who
require specialized care, rehabilitation services, or other services
associated with the transition between short-stay hospital care
and home. Risk factors and prophylaxis for venous thrombo-
embolism were collected by physicians, using a case report
form. Graduated compression stocking users were deﬁned as
patients who wore below-knee or thigh-length graduated
compression stockings for daytime hours or longer. Given
the observational nature of this study, physicians in charge of
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